MaxCyte
MXCT
MXCT
98 hedge funds and large institutions have $502M invested in MaxCyte in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
27% less capital invested
Capital invested by funds: $687M → $502M (-$185M)
Holders
98
Holding in Top 10
4
Calls
$37K
Puts
–
Top Buyers
| 1 | +$22.9M | |
| 2 | +$11.6M | |
| 3 | +$10.3M | |
| 4 |
Millennium Management
New York
|
+$9.84M |
| 5 |
VP
Vitruvian Partners
London,
United Kingdom
|
+$7.38M |
Top Sellers
| 1 | -$19M | |
| 2 | -$11.5M | |
| 3 | -$10.1M | |
| 4 |
QP
Quilter Plc
London,
United Kingdom
|
-$4.49M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.64M |